Bronchiolitis obliterans in heart-lung transplantation patients: radiologic findings in 11 patients

AJR. American Journal of Roentgenology
J L SkeensS A Yousem

Abstract

Patients who survive the postoperative period after combined heart-lung transplantation are at risk for developing progressive airway damage consisting of central bronchiectasis and bronchiolitis obliterans. The cause of these abnormalities is uncertain, but they are thought to represent a form of chronic rejection. The chest radiographs and medical records of 11 transplantation patients with proved bronchiolitis obliterans were reviewed retrospectively. A pathologic diagnosis was made by open-lung biopsy (five patients), transbronchial biopsy (three patients), and autopsy (two patients). Clinical criteria alone were used for diagnosis in one patient. In all patients, the chest radiographs showed parenchymal abnormalities consisting of linear-nodular, nodular, confluent nodular, or diffuse alveolar opacities. Radiographic evidence of central bronchiectasis was present in nine of the 11 patients. This feature was not present on chest radiographs of five randomly selected asymptomatic transplant patients. We conclude that the parenchymal lung changes in bronchiolitis obliterans in transplant patients are nonspecific and are radiographically indistinguishable from other infectious and noninfectious complications. The presence of c...Continue Reading

Citations

Jan 1, 1997·European Journal of Nuclear Medicine·M J O'Doherty, A M Peters
Apr 29, 2010·Current Gastroenterology Reports·Veerle MertensDaniel Sifrim
Dec 1, 1995·The Annals of Thoracic Surgery·H ReichenspurnerB A Reitz
Apr 1, 1991·Seminars in Roentgenology·D P Naidich
Mar 17, 2004·Current Opinion in Pulmonary Medicine·Andrew Chan, Roblee Allen
Dec 1, 1995·Journal of Cardiovascular Electrophysiology·F BogunF Morady
Jul 22, 2011·Pathology Research International·Mostafa GhaneiHenry D Tazelaar
Feb 1, 1995·The British Journal of Radiology·S PadleyC D Flower
Oct 1, 1995·Seminars in Ultrasound, CT, and MR·G McGuinness, D P Naidich
Oct 19, 2004·European Journal of Radiology·Mostafa GhaneiJafar Aslani
Aug 5, 2006·Pathology, Research and Practice·Javad BeheshtiMostafa Ghanei
Sep 1, 2006·Environmental Toxicology and Pharmacology·Mostafa GhaneiJafar Aslani
Dec 10, 1999·Clinics in Chest Medicine·J A Shepard
Jun 1, 1997·Clinics in Chest Medicine·C Chaparro, S Kesten
Jan 30, 2002·Radiologic Clinics of North America·Gayle M Waitches, Eric J Stern
Dec 12, 2002·Clinical Radiology·S P JensenJ D Newell
Feb 13, 2001·Annual Review of Medicine·D L DeMeo, L C Ginns
Apr 25, 2009·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Bruno HochheggerJosé Jesus Camargo
Jun 1, 1997·Clinics in Chest Medicine·K Kelly, M I Hertz
Jun 19, 2004·Inhalation Toxicology·Mostafa GhaneiFariborz Nematizadeh
Dec 12, 2001·Transplantation·D L DeMeo, L C Ginns
Jul 6, 2004·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Jung Im JungSeog Hee Park
Jan 1, 1994·Disease-a-month : DM·S G Jenkinson, S M Levine
Feb 18, 1998·Radiologic Clinics of North America·R M SloneR D Yusen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.